HK1143956A1 - Clay-based aromatised therapeutic composition - Google Patents

Clay-based aromatised therapeutic composition

Info

Publication number
HK1143956A1
HK1143956A1 HK10110577.8A HK10110577A HK1143956A1 HK 1143956 A1 HK1143956 A1 HK 1143956A1 HK 10110577 A HK10110577 A HK 10110577A HK 1143956 A1 HK1143956 A1 HK 1143956A1
Authority
HK
Hong Kong
Prior art keywords
clay
therapeutic composition
aromatised
dioctaedric
antidiarrheic
Prior art date
Application number
HK10110577.8A
Other languages
English (en)
Inventor
Jerome Barra
Hazif Denis Le
Original Assignee
Ipsen Pharma
Firmenich & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Pharma, Firmenich & Cie filed Critical Ipsen Pharma
Publication of HK1143956A1 publication Critical patent/HK1143956A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HK10110577.8A 2007-08-13 2010-11-12 Clay-based aromatised therapeutic composition HK1143956A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07291005A EP2025332A1 (fr) 2007-08-13 2007-08-13 Composition thérapeutique aromatisée à base d'argile
PCT/FR2008/001185 WO2009056703A1 (fr) 2007-08-13 2008-08-12 Composition thérapeutique aromatisée à base d'argile

Publications (1)

Publication Number Publication Date
HK1143956A1 true HK1143956A1 (en) 2011-01-21

Family

ID=39052728

Family Applications (2)

Application Number Title Priority Date Filing Date
HK10110577.8A HK1143956A1 (en) 2007-08-13 2010-11-12 Clay-based aromatised therapeutic composition
HK14109703.3A HK1196271A1 (zh) 2007-08-13 2014-09-26 粘土基的矯味治療組合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK14109703.3A HK1196271A1 (zh) 2007-08-13 2014-09-26 粘土基的矯味治療組合物

Country Status (27)

Country Link
US (2) US20100159013A1 (ar)
EP (3) EP2025332A1 (ar)
JP (2) JP5670189B2 (ar)
KR (2) KR101503957B1 (ar)
CN (2) CN101778622A (ar)
AR (2) AR067929A1 (ar)
BR (1) BRPI0814979A2 (ar)
CA (1) CA2696062C (ar)
CL (1) CL2008002366A1 (ar)
DK (1) DK2194968T3 (ar)
EA (1) EA017118B1 (ar)
ES (2) ES2421379T3 (ar)
GE (1) GEP20125539B (ar)
HK (2) HK1143956A1 (ar)
HU (1) HUE029713T2 (ar)
MA (1) MA31678B1 (ar)
ME (1) ME00975B (ar)
MX (1) MX2010001533A (ar)
NO (1) NO20100114L (ar)
PE (1) PE20090939A1 (ar)
PL (2) PL2194968T3 (ar)
PT (2) PT2194968E (ar)
SA (1) SA08290496B1 (ar)
TN (1) TN2010000058A1 (ar)
TW (2) TWI519303B (ar)
UA (1) UA97408C2 (ar)
WO (1) WO2009056703A1 (ar)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2025332A1 (fr) * 2007-08-13 2009-02-18 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Composition thérapeutique aromatisée à base d'argile
FR2952814B1 (fr) * 2009-11-23 2013-07-19 Ephyla Sas Composition comprenant un complexe de phyllosilicates organiquement modifies generer des emulsions huile dans eau eventuellement a froid
EP2663281B1 (en) 2011-01-12 2016-08-10 Sooft Italia Spa Corneal delivery of cross-linking agents by iontophoresis for the treatment of keratoconus and related ophthalmic compositions
ITUA20162277A1 (it) * 2016-04-04 2017-10-04 Chemists Res Srl Composizione comprendente diosmectite
CN105902625A (zh) * 2016-05-26 2016-08-31 朱胜利 一种小儿止泻药的服用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4635285A (en) * 1984-07-16 1986-02-10 Sunkist Growers, Inc. Solid essential oil flavor composition and method of manufacture
US4707367A (en) 1984-07-16 1987-11-17 Sunkist Growers, Inc. Solid essential oil flavor composition
JPH064530B2 (ja) * 1985-02-23 1994-01-19 日本化薬株式会社 親水性基剤
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
JPH08509018A (ja) * 1993-04-16 1996-09-24 マコーミック アンド カンパニー，インク． カプセル化組成物
FR2770778B1 (fr) * 1997-11-12 2000-05-26 Investigations Therapeutiques Composition pour le traitement des gastro-enterites aigues, procede de fabrication de cette composition et solution de traitement obtenue a partir de cette composition
KR20030050958A (ko) * 2001-12-20 2003-06-25 송우영 디옥타헤드랄 스멕타이트를 유효성분으로 함유하는 항균성외용조성물
US8334007B2 (en) * 2003-03-19 2012-12-18 Firmenich Sa Continuous process for the incorporation of a flavor or fragrance ingredient or composition into a carbohydrate matrix
CN100340235C (zh) * 2004-05-21 2007-10-03 山东绿叶制药有限公司 蒙脱石分散片及其制备工艺
EP1627573A1 (en) * 2004-08-20 2006-02-22 Firmenich Sa A process for the incorporation of a flavor or fragrance ingredient or composition into a carbohydrate matrix
JP2006083071A (ja) * 2004-09-14 2006-03-30 Takasago Internatl Corp 香粧品用固形製剤
WO2007051427A1 (fr) * 2005-11-04 2007-05-10 Zhejiang Hailisheng Pharmaceutical Limited Co. Montmorillonite modifiee, son procede de preparation et ses utilisations
FR2901360A1 (fr) 2006-05-16 2007-11-23 Horiba Abx Sas Soc Par Actions Dispositif de conditionnement pour analyse biologique
EP2025332A1 (fr) * 2007-08-13 2009-02-18 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Composition thérapeutique aromatisée à base d'argile

Also Published As

Publication number Publication date
CA2696062A1 (fr) 2009-05-07
EP2710998B1 (fr) 2016-04-20
EP2194968A1 (fr) 2010-06-16
EP2710998A1 (fr) 2014-03-26
TW201509424A (zh) 2015-03-16
SA08290496B1 (ar) 2012-11-03
TW200914034A (en) 2009-04-01
TWI511734B (zh) 2015-12-11
EA017118B1 (ru) 2012-09-28
GEP20125539B (en) 2012-05-25
CA2696062C (fr) 2017-09-05
US20100159013A1 (en) 2010-06-24
CL2008002366A1 (es) 2009-05-29
US9056055B2 (en) 2015-06-16
JP2014208715A (ja) 2014-11-06
AR067929A1 (es) 2009-10-28
WO2009056703A8 (fr) 2010-03-04
EP2025332A1 (fr) 2009-02-18
BRPI0814979A2 (pt) 2015-02-03
US20140377354A1 (en) 2014-12-25
CN104173371A (zh) 2014-12-03
NO20100114L (no) 2010-03-10
TWI519303B (zh) 2016-02-01
KR20100055460A (ko) 2010-05-26
KR20140133617A (ko) 2014-11-19
MA31678B1 (ar) 2010-09-01
PT2710998T (pt) 2016-07-28
AR114148A2 (es) 2020-07-29
TN2010000058A1 (fr) 2011-09-26
CN101778622A (zh) 2010-07-14
ES2421379T3 (es) 2013-09-02
EP2194968B1 (fr) 2013-06-19
JP2010535852A (ja) 2010-11-25
EA201070257A1 (ru) 2010-06-30
DK2194968T3 (da) 2013-09-02
ES2582871T3 (es) 2016-09-15
PE20090939A1 (es) 2009-07-27
PL2710998T3 (pl) 2016-11-30
HK1196271A1 (zh) 2014-12-12
WO2009056703A1 (fr) 2009-05-07
ME00975B (me) 2012-06-20
KR101503957B1 (ko) 2015-03-18
PL2194968T3 (pl) 2013-10-31
UA97408C2 (ru) 2012-02-10
JP5670189B2 (ja) 2015-02-18
HUE029713T2 (en) 2017-03-28
PT2194968E (pt) 2013-07-25
MX2010001533A (es) 2010-03-15

Similar Documents

Publication Publication Date Title
WO2007025613A3 (en) Use of compounds binding to the sigma receptor for the treatment of diabetes-associated pain
WO2006089665A3 (de) Wirkstoffkombinationen mit insektiziden und akariziden eigenschaften
MX2010005889A (es) Derivados de tiofeno como agonistas de s1p1/edg1.
WO2009039951A3 (de) Wirkstoffkombinationen mit insektiziden und akariziden eigenschaften
WO2009017837A3 (en) Sublingual fentanyl spray
WO2007127158A3 (en) Modification of percutaneous absorption of topically active materials
WO2007087431A3 (en) Sublingual fentanyl spray
HK1143956A1 (en) Clay-based aromatised therapeutic composition
MY147949A (en) Hydrogenated benzo[c]thiophene derivatives as immunomodulators
WO2009074735A3 (fr) Utilisation d'un nouvel agent naturel dans des compositions cosmetiques
IL196108A0 (en) Active agent formulations, methods of making, and methods of use
WO2005089728A3 (en) Means for transdermal administration of nicotine
WO2007025005A3 (en) Sustained release formulations of nalbuphine
HK1122723A1 (en) Intranasal administration of active agents to the central nervous system
WO2009078447A1 (ja) 抗ノロウイルス剤、抗インフルエンザウイルス剤、およびこれらを用いた抗ウイルス処理方法
TW200942530A (en) Pyridine compounds
WO2011103146A3 (en) A post foaming gel composition comprising an anti-irritation agent
TW200942524A (en) Novel aminomethyl benzene derivatives
WO2011077239A3 (en) Slow release pharmaceutical compositions of iloperidone
EP1731609A4 (en) INHIBITOR OF THE EXPRESSION OF RAD51, MEDICAMENT CONTAINING THE INHIBITOR AS ACTIVE INGREDIENT AND USE THEREOF
IL191758A0 (en) Composition with sustained release of the active ingredient, process for the preparation thereof and use thereof
EP2438923A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF OBESITY-RELATED DISORDERS MEDIATED BY AMPK ACTIVATION AND THE ACTIVE INGREDIENTS OF WHICH HAVE 2,5-BIS-ARYL-3,4-DIMETHYLTETRAHYDROFURAN LIGNANS
WO2007136741A3 (en) N-desmethyl-doxepin and methods of using the same to treat sleep disorders
WO2006076097A3 (en) Stable non-crystalline formulation comprising losartan
UA97401C2 (ru) Экструдат с улучшенной маскировкой вкуса